Takahiro Haeno, Shinya Rai, Yoshiaki Miyake, Maiko Inoue, Ko Fujimoto, Aki Fujii, Yoshio Iwata, Shuji Minamoto, Takahide Taniguchi, Hiroaki Kakutani, et al. Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma. Journal of clinical and experimental hematopathology : JCEH. 2023. 63. 2. 99-107
Kentaro Serizawa, Hirokazu Tanaka, Takeshi Ueda, Ayano Fukui, Hiroaki Kakutani, Takahide Taniguchi, Hiroaki Inoue, Takahiro Kumode, Yasuhiro Taniguchi, Shinya Rai, et al. CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence. International Journal of Hematology. 2022. 115. 3. 336-349
Shinya Rai, Hiroaki Inoue, Kazuko Sakai, Hitoshi Hanamoto, Mitsuhiro Matsuda, Yasuhiro Maeda, Takahiro Haeno, Yosaku Watatani, Takahiro Kumode, Kentaro Serizawa, et al. Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma. Cancer science. 2022. 113. 2. 660-673
Shinya Rai, Hiroaki Inoue, Hitoshi Hanamoto, Mitsuhiro Matsuda, Yasuhiro Maeda, Yusuke Wada, Takahiro Haeno, Yosaku Watatani, Takahiro Kumode, Chikara Hirase, et al. Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trial. International journal of hematology. 2021. 114. 2. 205-216
Hiroaki Inoue, Shinya Rai, Hirokazu Tanaka, J. Luis Espinoza, Maiko Komori-Inoue, Hiroaki Kakutani, Shuji Minamoto, Takahiro Kumode, Shoko Nakayama, Yasuhiro Taniguchi, et al. Epstein-Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-Immunotherapy. Viruses. 2020. 12. 4. 416-416
